Service Quote Request
Please fill out the form below with your detailed inquiry.
A lentivirus pseudotyped envelope refers to the viral surface glycoprotein used to coat a lentiviral vector, which determines how the virus enters cells, which cell types it can infect, and how stable the virus is. It is one of the most important design choices in lentiviral vector production.
Native HIV-1 uses its own envelope (gp120/gp41), but lentiviral vectors do not. Instead, they are produced with a heterologous viral envelope protein supplied on a separate plasmid. This process is called pseudotyping.
It lets you:
The pseudotyped envelope controls four critical properties:
| Property | Controlled by envelope |
|---|---|
| Cell targeting | Which receptors the virus binds |
| Entry mechanism | Endocytosis vs membrane fusion |
| Stability | Whether virus survives centrifugation & freezing |
| In vivo performance | Liver, CNS, tumor, immune cell targeting |
Your lentivector genome stays the same — only the envelope protein changes the biology.
The gold standard.
Used for:
HEK293, neurons, stem cells, tumor cells, mouse injections, organoids
Preferred for human hematopoietic cells.
High-efficiency transduction of immune cells.
Receptor-targetable envelopes.
In a 3rd-generation system (what SignaGen uses), the envelope is provided on a separate plasmid:
| Plasmid | Function |
|---|---|
| Transfer vector | Your gene |
| Packaging plasmids | Gag, Pol, Rev |
| Envelope plasmid | VSV-G, RD114, BaEV, etc |
The envelope protein is incorporated into the viral membrane as particles bud from the producer cells.
The envelope determines:
Two lentiviruses with identical genomes but different envelopes behave like completely different viruses.
Think of the lentivirus as a delivery drone:
Change the envelope → you change where it can go and what it can enter.
Please contact us at info@signagen.com to discuss your lentivirus project